The diagnosis and management of pre-invasive breast disease: pathological diagnosis--problems with existing classifications.
In this review, we comment on the reasons for disagreement in the concepts, diagnosis and classifications of pre-invasive intraductal proliferations. In view of these disagreements, our proposal is to distinguish epithelial hyperplasia, lobular carcinoma in situ and ductal carcinoma in situ, and to abandon the use of poorly reproducible categories, such as atypical ductal hyperplasia or ductal intraepithelial neoplasia, followed by a number to indicate the degree of proliferation and atypia, as these are not practical for clinical decision making, nor for studies aimed at improving the understanding of breast cancer development. If there is doubt about the classification of an intraductal proliferation, a differential diagnosis and the reason for and degree of uncertainty should be given, rather than categorizing a proliferation as atypical.
Van de Vijver
Marc J
MJ
Netherlands Cancer Institute, Amsterdam, The Netherlands. m.vd.vijver@nki.nl
Peterse
Hans
H
D001943:Breast Neoplasms / Q000145:classification* / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D009361:Neoplasm Invasiveness